New Research Poster Presentation 4.55: Evaluation of the Tolerability and Effectiveness of the Methylphenidate Transdermal System Over 6 Months in Adolescents with ADHD

Friday, October 30, 2009 9:00 AM

Alain Katic, M.D., Houston, TX

Robert L. Findling, M.D., University Hospitals Case Medical Center, Cleveland, OH

Richard Rubin, M.D., Vermont Clinical Study Center, Burlington, VT

Manisha Madhoo, M.D., Shire Pharmaceuticals Inc., Wayne, PA

Richard Civil, M.D., Clinical Development and Medical Affairs, Shire Pharmaceuticals Inc., Wayne, PA

Yunfeng Li, Ph.D., Shire Pharmaceuticals Inc., Wayne, PA

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 4.55 Evaluation of the Tolerability and Effectiveness of the Methylphenidate Transdermal System Over 6 Months in Adolescents with ADHD